BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11365763)

  • 1. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C and HIV: ribavirin plus interferon study recruiting.
    AIDS Treat News; 1998 May; (No 295):5. PubMed ID: 11365407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin approved with a big fat price.
    Falkenberg J
    Notes Undergr; 1998; (No 37):10-1. PubMed ID: 11365818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C important treatment advance: interview with Douglas Dieterich, M.D. Interview by John S. James.
    Dieterich D
    AIDS Treat News; 1998 May; (No 295):1-5. PubMed ID: 11365406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin for hepatitis C: 80% price reduction available July 9?
    James JS
    AIDS Treat News; 1999 Jul; (No 322):3-4. PubMed ID: 11366565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia during treatment of hepatitis C in HIV-infected patients.
    Lo Re V; Kostman JR
    AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marketing scam spoils hep C treatment.
    Proj Inf Perspect; 1998 Dec; (26):6. PubMed ID: 11366498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.
    Yachimski P; Chung RT
    AIDS Read; 2004 Oct; 14(10):568-9. PubMed ID: 15510393
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus statement to Schering-Plough Pharmaceuticals from the health care community regarding Rebetron development and marketing.
    Notes Undergr; 1999; (No 39):9-13. PubMed ID: 11366786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
    Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
    Chevaliez S; Brillet R; Lázaro E; Hézode C; Pawlotsky JM
    J Virol; 2007 Jul; 81(14):7732-41. PubMed ID: 17494069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis C virus/HIV coinfection.
    Chun S; Sherman KE
    Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
    Shakil AO; McGuire B; Crippin J; Teperman L; Demetris AJ; Conjeevaram H; Gish R; Kwo P; Balan V; Wright TL; Brass C; Rakela J
    Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV/HIV co-infection therapy.
    Pietrandoni G
    Posit Aware; 2002; 13(2):32, 38. PubMed ID: 12004829
    [No Abstract]   [Full Text] [Related]  

  • 19. Ribavirin approved for hepatitis C combination treatment.
    James JS
    AIDS Treat News; 1998 Jun; (No 297):7. PubMed ID: 11365595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy for hepatitis C.
    TreatmentUpdate; 1998 Mar; 10(1):2-3. PubMed ID: 11365430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.